0001193125-21-170873.txt : 20210624 0001193125-21-170873.hdr.sgml : 20210624 20210524161528 ACCESSION NUMBER: 0001193125-21-170873 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC CENTRAL INDEX KEY: 0001845337 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832415215 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BLVD STE 217 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080-1930 BUSINESS PHONE: 206-913-4300 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BLVD STE 217 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080-1930 FORMER COMPANY: FORMER CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC DATE OF NAME CHANGE: 20210209 CORRESP 1 filename1.htm CORRESP

Day One Biopharmaceuticals Holding Company, LLC

395 Oyster Point Blvd., Suite 217

South San Francisco, CA 94080

May 24, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

 

Attention:

Abby Adams

    

Christine Westbrook

    

Li Xiao

    

Kevin Kuhar

 

Re:

Day One Biopharmaceuticals Holding Company, LLC Registration Statement on Form S-1 (File No. 333-255754) originally filed May 4, 2021, as amended, and corresponding Registration Statement on Form 8-A (File No. 001-40431) filed May 24, 2021

Requested Date: May 26, 2021

Requested Time: 4:30 PM Eastern Time

Ladies and Gentlemen:

Day One Biopharmaceuticals Holding Company, LLC (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 and Form 8-A effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

The Registrant hereby authorizes Robert A. Freedman or Julia Forbess, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, Ms. Forbess at (415) 875-2420.

*    *    *

Sincerely,
DAY ONE BIOPHARMACEUTICALS HOLDING COMPANY, LLC
By:   /s/ Jeremy Bender, Ph.D., M.B.A.
  Jeremy Bender, Ph.D., M.B.A.
  Chief Executive Officer

 

cc:

Robert A. Freedman, Esq.

    

Effie Toshav, Esq.

    

Julia Forbess, Esq.

    

Fenwick & West LLP

 

[Signature Page to Company Acceleration Request Letter]